FDA
label_change
· 2024-05-22
FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
Summary
FDA approved a supplemental application for SAVELLA (milnacipran hydrochloride) by Allergan to update the drug labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SAVELLA (MILNACIPRAN HYDROCHLORIDE)